These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9230196)

  • 1. Normal polymorphism in the incomplete trinucleotide repeat of the arginine-rich protein gene.
    Evron E; Cairns P; Halachmi N; Ahrendt SA; Reed AL; Sidransky D
    Cancer Res; 1997 Jul; 57(14):2888-9. PubMed ID: 9230196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the arginine-rich protein gene, in lung, breast, and prostate cancers, and in squamous cell carcinoma of the head and neck.
    Shridhar R; Shridhar V; Rivard S; Siegfried JM; Pietraszkiewicz H; Ensley J; Pauley R; Grignon D; Sakr W; Miller OJ; Smith DI
    Cancer Res; 1996 Dec; 56(24):5576-8. PubMed ID: 8971156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A gene from human chromosomal band 3p21.1 encodes a highly conserved arginine-rich protein and is mutated in renal cell carcinomas.
    Shridhar V; Rivard S; Shridhar R; Mullins C; Bostick L; Sakr W; Grignon D; Miller OJ; Smith DI
    Oncogene; 1996 May; 12(9):1931-9. PubMed ID: 8649854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the arginine-rich protein gene (ARP) in pancreatic cancer.
    Shridhar V; Rivard S; Wang X; Shridhar R; Paisley C; Mullins C; Beirnat L; Dugan M; Sarkar F; Miller OJ; Vaitkevicius VK; Smith DI
    Oncogene; 1997 May; 14(18):2213-6. PubMed ID: 9174057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic organization and mutation analysis of Hel-N1 in lung cancers with chromosome 9p21 deletions.
    Cairns P; Okami K; King P; Bonacum J; Ahrendt S; Wu L; Mao L; Jen J; Sidransky D
    Cancer Res; 1997 Dec; 57(23):5356-9. PubMed ID: 9393760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
    Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR
    Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KLF6: mutational analysis and effect on cancer cell proliferation.
    Yin D; Komatsu N; Miller CW; Chumakov AM; Marschesky A; McKenna R; Black KL; Koeffler HP
    Int J Oncol; 2007 Jan; 30(1):65-72. PubMed ID: 17143513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
    Lerman MI; Minna JD
    Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of the FHIT gene at 3p14.2 in lung cancer cell lines.
    Yanagisawa K; Kondo M; Osada H; Uchida K; Takagi K; Masuda A; Takahashi T; Takahashi T
    Cancer Res; 1996 Dec; 56(24):5579-82. PubMed ID: 8971157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent loss of heterozygosity in region of the KIP1 locus in non-small cell lung cancer: evidence for a new tumor suppressor gene on the short arm of chromosome 12.
    Takeuchi S; Mori N; Koike M; Slater J; Park S; Miller CW; Miyoshi I; Koeffler HP
    Cancer Res; 1996 Feb; 56(4):738-40. PubMed ID: 8631006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors.
    Medina PP; Carretero J; Fraga MF; Esteller M; Sidransky D; Sanchez-Cespedes M
    Genes Chromosomes Cancer; 2004 Oct; 41(2):170-7. PubMed ID: 15287030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
    Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
    Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.
    Burke L; Khan MA; Freedman AN; Gemma A; Rusin M; Guinee DG; Bennett WP; Caporaso NE; Fleming MV; Travis WD; Colby TV; Trastek V; Pairolero PC; Tazelaar HD; Midthun DE; Liotta LA; Harris CC
    Cancer Res; 1998 Jun; 58(12):2533-6. PubMed ID: 9635574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer.
    Brachman DG; Graves D; Vokes E; Beckett M; Haraf D; Montag A; Dunphy E; Mick R; Yandell D; Weichselbaum RR
    Cancer Res; 1992 Sep; 52(17):4832-6. PubMed ID: 1324797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic structure of the human ING1 gene and tumor-specific mutations detected in head and neck squamous cell carcinomas.
    Gunduz M; Ouchida M; Fukushima K; Hanafusa H; Etani T; Nishioka S; Nishizaki K; Shimizu K
    Cancer Res; 2000 Jun; 60(12):3143-6. PubMed ID: 10866301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers.
    Nagatake M; Takagi Y; Osada H; Uchida K; Mitsudomi T; Saji S; Shimokata K; Takahashi T; Takahashi T
    Cancer Res; 1996 Jun; 56(12):2718-20. PubMed ID: 8665501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of FHIT function in lung cancer and preinvasive bronchial lesions.
    Sozzi G; Pastorino U; Moiraghi L; Tagliabue E; Pezzella F; Ghirelli C; Tornielli S; Sard L; Huebner K; Pierotti MA; Croce CM; Pilotti S
    Cancer Res; 1998 Nov; 58(22):5032-7. PubMed ID: 9823304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.
    Chung KY; Mukhopadhyay T; Kim J; Casson A; Ro JY; Goepfert H; Hong WK; Roth JA
    Cancer Res; 1993 Apr; 53(7):1676-83. PubMed ID: 8453641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer.
    Gao WM; Romkes M; Day RD; Siegfried JM; Luketich JD; Mady HH; Melhem MF; Keohavong P
    Carcinogenesis; 2003 Oct; 24(10):1671-6. PubMed ID: 12844488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.